HAEMONETICS CORP — Director's Dealing 2017

Nov 15, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2016-04-07

Reporting Person: Goldstein Dan (Chief Accounting Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2397	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-qualified Stock Option (Right to Buy)	$34.42	2023-04-06	Common Stock (10428)		Direct

Footnotes

F1: Mr. Goldstein was appointed Chief Accounting Officer April 7, 2016. This grant was made in connection with his appointment and represents Restricted Stock Units which vest 25% per year over 4 years following the grant date.

F2: Non-qualified stock option grant providing a right to buy shares of common stock exercisable in annual increments of 25% beginning on the first anniversary of the date of grant.